IAVI
Hayden R. Schmidt is a Principal Scientist at IAVI, specializing in AMR Immunotherapeutics since April 2021, following progressive roles in antibody discovery and development. Prior experience includes a Postdoctoral Fellow position in Richard Benton's laboratory at the University of Lausanne, focusing on insect chemoreceptors, and a PhD candidacy at Harvard University under Andrew Kruse, where structural pharmacology of sigma receptors was explored. Academic foundations were built at Whittier College with a Bachelor's Degree in Biology and Chemistry, complemented by undergraduate research assistance at the University of California, San Diego, concentrating on zebrafish models for pesticide toxicity.
This person is not in any offices
IAVI
Translating scientific discoveries into affordable, globally accessible public health solutions. IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases.